Mstar Small Value Index Ishares (JKL) 132.57

New Post Public Reply Private Reply Replies (0) Message Board

Mar 22, 2015 at 1:37 AM

Mstar Small Value Index Ishares (JKL) 132.57 $JKL

Direxion Funds launches 3 smart-beta ETFs
Seeking Alpha - at Seeking Alpha - Wed Mar 11, 12:50PM CDT

IWS: 76.60 (+0.86), VTV: 85.19 (+0.74), SYV: 56.56 (unch), FYT: 33.68 (+0.36), SJL: 61.99 (unch), IWX: 44.25 (+0.50), EES: 84.75 (+1.17), IESM: 33.23 (+0.34), UVU: 95.57 (+3.57), TILT: 89.92 (+0.87), VBR: 110.09 (+1.14), VLU: 84.42 (-0.25), SCHV: 44.24 (+0.43), IELG: 32.76 (+0.29), PWV: 31.36 (+0.18), VLML: 25.28 (unch), VOE: 92.73 (+0.97), GVT: 45.55 (unch), EZY: 67.90 (+0.90), JKI: 127.66 (+1.35), JKL: 132.57 (+1.47), JKF: 85.38 (+0.81), VLSM: 25.46 (unch), FNK: 31.38 (+0.34), VLLV: 25.72 (+0.26)

Dynamics Of A New Regime: What's Changed Around The World?
Nanette Abuhoff Jacobson - Seeking Alpha - Fri Nov 21, 5:21AM CST
On October 15, the world suddenly seemed to change. At one point that day, the S&P 500 Index was down over 2%, European stocks fell 3.5%, sovereign spreads widened in peripheral European countries, 10-year U.S. Treasury yields briefly dropped...
IWS: 76.60 (+0.86), VTV: 85.19 (+0.74), IWR: 175.91 (+1.54), DBEU: 29.69 (+0.31), IWP: 99.54 (+0.71), VO: 130.27 (+1.11), EET: 69.60 (+1.82), SYV: 56.56 (unch), EEV: 18.47 (-0.53), CHXF: 53.25 (-0.02), IEUR: 46.52 (+1.12), IWY: 53.15 (+0.49), DBEM: 22.23 (+0.17), UPV: 48.39 (+2.14), IWX: 44.25 (+0.50), EES: 84.75 (+1.17), EWJ: 12.81 (+0.20), ADRE: 35.28 (+0.42), EEM: 40.08 (+0.59), VB: 123.44 (+1.15), EEH: 15.64 (+0.18), FTC: 49.63 (+0.35), PWB: 31.41 (+0.33), VLU: 84.42 (-0.25), VBR: 110.09 (+1.14), PGJ: 29.21 (+0.92), JPP: 48.16 (+0.75), SYG: 59.72 (unch), ILF: 29.57 (+0.85), GXC: 82.40 (+0.45), EMFT: 46.33 (unch), PWV: 31.36 (+0.18), ADRU: 23.48 (+0.56), EDZ: 33.42 (-1.54), SYE: 58.56 (unch), RWG: 48.18 (+1.35), GVT: 45.55 (unch), VBK: 135.66 (+1.03), MCHI: 52.97 (+0.18), EWV: 50.27 (-1.14), VUG: 110.43 (+0.93), IEV: 45.29 (+1.11), EDC: 23.63 (+0.95), IWL: 47.90 (+0.38), FJP: 50.61 (+0.48), YXI: 26.63 (-1.41), EMSA: 65.54 (unch), EMCR: 20.02 (+0.13), YINN: 39.08 (+0.56), SJL: 61.99 (unch), EUM: 25.53 (-0.36), ESTX: 47.80 (+1.54), GML: 47.51 (+1.32), GMM: 64.12 (+0.77), IELG: 32.76 (+0.29), EWEM: 32.08 (+0.38), EMDR: 50.00 (-0.01), EEML: 33.25 (+1.16), EEME: 42.79 (+0.54), FWDD: 44.49 (+0.48), VV: 97.40 (+0.88), FLN: 17.27 (+0.46), IEMG: 48.25 (+0.63), FEX: 47.29 (+0.43), FEZ: 39.29 (+1.10), VGK: 55.87 (+1.41), SCHA: 58.29 (+0.46), FIEU: 119.23 (+5.93), FEP: 31.62 (+0.65), SCHE: 24.27 (+0.26), UKW: 116.13 (+4.04), SDK: 60.50 (-0.50), SCHG: 55.11 (+0.42), FEU: 36.03 (+0.69), NKY: 19.38 (+0.35), HEDJ: 66.87 (+0.74), DXJ: 56.03 (+0.41), ITF: 54.87 (+0.74), ERW: 54.77 (+0.55), LBJ: 8.91 (+0.65), SCHM: 43.68 (+0.38), FXP: 37.81 (-0.37), FEM: 21.92 (+0.34), YAO: 28.48 (+0.18), SCHV: 44.24 (+0.43), FXI: 43.34 (+0.19), EMLB: 85.00 (-11.44), XPP: 74.44 (+0.77), SCHX: 50.69 (+0.43), JPNL: 57.79 (+2.66), FNX: 55.07 (+0.63), FNY: 31.57 (+0.31), JPNS: 24.62 (+0.12), EZU: 39.08 (+1.08), EZY: 67.90 (+0.90), YANG: 9.49 (-0.08), HEWJ: 30.96 (+0.33), HEEM: 24.52 (+0.19), FNK: 31.38 (+0.34), SFK: 20.51 (-1.28), FYX: 51.14 (+0.57), FEUZ: 32.88 (+0.78), MIDU: 115.45 (+3.51), FYT: 33.68 (+0.36), IESM: 33.23 (+0.34), UVU: 95.57 (+3.57), EPV: 54.01 (-2.86), MIDZ: 9.94 (-0.32), EZM: 97.35 (+0.92), TILT: 89.92 (+0.87), DBJP: 42.17 (+0.36), FCA: 23.29 (+0.19), EZJ: 99.33 (+3.08), CZA: 51.59 (+0.29), HEZU: 29.31 (+0.39), EMHZ: 22.42 (unch), EURL: 34.21 (+2.36), FEEU: 115.60 (+6.09), VOE: 92.73 (+0.97), JKI: 127.66 (+1.35), JKJ: 145.56 (+1.69), EURZ: 38.16 (+1.12), JKK: 145.33 (+1.07), JKL: 132.57 (+1.47), JKE: 121.98 (+1.00), JKF: 85.38 (+0.81), EQL: 57.89 (+0.55), VWO: 40.72 (+0.50), JKG: 155.25 (+1.49), EWRM: 52.62 (+0.34), JKH: 168.50 (+0.65), VOT: 109.00 (+0.77), CN: 37.41 (unch), FYC: 31.85 (+0.31), JKD: 124.23 (+1.12)

No Market Is An Island
Nanette Abuhoff Jacobson - Seeking Alpha - Fri Oct 24, 4:21PM CDT
As the final quarter of the year begins, I sense that we've entered a new regime - one defined by the interplay among central bank policies in the U.S., Europe, and Japan and their impact across asset classes. The U.S. is nearing its first rate hike...
VTV: 85.19 (+0.74), IWS: 76.60 (+0.86), IWR: 175.91 (+1.54), IWP: 99.54 (+0.71), VO: 130.27 (+1.11), IEFA: 59.77 (+1.31), EET: 69.60 (+1.82), SYV: 56.56 (unch), EEV: 18.47 (-0.53), IWY: 53.15 (+0.49), DBEM: 22.23 (+0.17), IWX: 44.25 (+0.50), EES: 84.75 (+1.17), ADRE: 35.28 (+0.42), EEM: 40.08 (+0.59), ADRD: 23.89 (+0.49), VB: 123.44 (+1.15), EEH: 15.64 (+0.18), FTC: 49.63 (+0.35), PWB: 31.41 (+0.33), VBR: 110.09 (+1.14), VLU: 84.42 (-0.25), SYG: 59.72 (unch), EMFT: 46.33 (unch), PWV: 31.36 (+0.18), EDZ: 33.42 (-1.54), SYE: 58.56 (unch), RWG: 48.18 (+1.35), GVT: 45.55 (unch), VBK: 135.66 (+1.03), VUG: 110.43 (+0.93), DBEF: 30.51 (+0.28), EDC: 23.63 (+0.95), IWL: 47.90 (+0.38), EMSA: 65.54 (unch), VEA: 40.86 (+0.86), EMCR: 20.02 (+0.13), SJL: 61.99 (unch), EUM: 25.53 (-0.36), URTH: 74.81 (+1.12), GMM: 64.12 (+0.77), IELG: 32.76 (+0.29), EFZ: 31.72 (-0.73), EWEM: 32.08 (+0.38), EMDR: 50.00 (-0.01), EEME: 42.79 (+0.54), EFU: 37.50 (-1.68), FWDI: 27.51 (+0.76), EFO: 109.83 (+3.83), FWDD: 44.49 (+0.48), VV: 97.40 (+0.88), EFA: 65.66 (+1.42), IDHQ: 20.51 (+0.35), IEMG: 48.25 (+0.63), MFLA: 190.00 (unch), FEX: 47.29 (+0.43), SCHA: 58.29 (+0.46), SCHE: 24.27 (+0.26), UKW: 116.13 (+4.04), SCHG: 55.11 (+0.42), SDK: 60.50 (-0.50), SCHM: 43.68 (+0.38), ERW: 54.77 (+0.55), FEM: 21.92 (+0.34), SCHV: 44.24 (+0.43), TIP: 113.76 (+0.34), EMLB: 85.00 (-11.44), SCHX: 50.69 (+0.43), HEFA: 28.41 (+0.24), FNX: 55.07 (+0.63), FNY: 31.57 (+0.31), FDT: 51.19 (+0.76), EZY: 67.90 (+0.90), DPK: 27.69 (-2.00), HEEM: 24.52 (+0.19), IFSM: 45.62 (-0.22), FNK: 31.38 (+0.34), FYX: 51.14 (+0.57), SFK: 20.51 (-1.28), MIDU: 115.45 (+3.51), FYT: 33.68 (+0.36), IESM: 33.23 (+0.34), UVU: 95.57 (+3.57), MIDZ: 9.94 (-0.32), EZM: 97.35 (+0.92), TILT: 89.92 (+0.87), DZK: 70.40 (+4.31), CZA: 51.59 (+0.29), EMHZ: 22.42 (unch), VOE: 92.73 (+0.97), JKI: 127.66 (+1.35), JKJ: 145.56 (+1.69), JKK: 145.33 (+1.07), JKL: 132.57 (+1.47), JKE: 121.98 (+1.00), EQL: 57.89 (+0.55), JKF: 85.38 (+0.81), VWO: 40.72 (+0.50), JKG: 155.25 (+1.49), JKH: 168.50 (+0.65), EWRM: 52.62 (+0.34), VOT: 109.00 (+0.77), FYC: 31.85 (+0.31), JKD: 124.23 (+1.12)

Investor Guide to Small-Cap Value ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Oct 08, 11:00AM CDT
For investors considering small cap value ETFs, this guide to the space should be your starting point.
DES: 72.49 (+0.88), IWN: 104.24 (+1.26), JKL: 132.57 (+1.47), VBR: 110.09 (+1.14)

JKL, VGT, VCR, DWA, AEL, DSGX Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Sep 04, 9:57AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of iShares Morningstar Small Value Index Fund (NYSE:JKL), Vanguard Information Technology Etf (NYSE:VGT), Vanguard Consumer Discretionary ETF (NYSE:VCR), Dreamworks Animation Skg Inc (NASDAQ

WA), American Equity Investment Life Holding Co (NYSE:AEL), DESCARTES SYSTEMS GRP/THE (NASDAQ

SGX) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
VCR: 124.36 (+1.22), AEL: 28.94 (+0.32), JKL: 132.57 (+1.47), DSGX: 15.09 (-0.08), DWA: 22.00 (+0.12), VGT: 108.77 (+0.62)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Protecting Teeth: Insights from Endodontist Dr. Joubert

Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...

Larry Ellison's Moves Signal Confidence in Oracle's Future

Unraveling Ellison's Bold Decision There's nothing like a sudden shift from a tech titan to make Wall Street sit up and take notice. Today, we got the word that Larry Ellison, Oracle's big gun as Executive Chair and CTO, has pulled the plug on his plan to sell Oracle stock. No dice, no distance covered under that plan. And he's made it crystal clear—selling isn't on his...

Damp or Dry: The Battle for Healthy Air in Colorado

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Ajman Spotlights Tourism at Arabian Travel Market 2026

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

OneOdio Showcases Innovation at IFA 2026 in Berlin

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...